Gsk Share Discussion Threads

[geckotheglorious] 18/4/2023 08:19

TraderMichael,

What did it do?

It ended the "congolmerate" style nature of the business and got rid of the stable cash flow.

Now more a pharma focused company, sadly.

Now more dependent on R&D successes.

If I want to buy a Pharma, Pfizer fits the bill. Wont touch GSK personally.

Haleon looks very interesting going forward, especially around the 270-285 level.

[tradermichael] 18/4/2023 08:16

So what did selling a company (Haleon) do?

[alibizzle] 18/4/2023 08:04

Buying out a company makes GSK less likely to be bought itself so good move

[patientcapital] 18/4/2023 08:03

Wally:"The Company's issued share capital as at 31 March 2023 consisted of 4,312,015,636 shares of 31 1/4 pence each ('Ordinary Shares'), of which 217,068,169 Ordinary Shares were held in Treasury."

[tradermichael] 18/4/2023 08:01

Earnings accretive, but 2026/7 is a long way off .......

GSK PLC said Tuesday that it has reached an agreement to buy the late-stage biopharmaceutical company BELLUS Health Inc. for $14.75 a share in cash, representing a total equity value of around $2.0 billion.

The pharmaceutical giant said the deal will provide access to camlipixant, a treatment for refractory chronic cough currently in phase III development.

Following the anticipated regulatory approval and launch of camlipixant in 2026, the acquisition of the Canada-based company is expected to be accretive to adjusted earnings per share--which strips out exceptional and other one-off items--from 2027 and has the potential to deliver significant sales through 2031 and beyond, it added.

"This proposed acquisition complements our portfolio of specialty medicines and builds on our expertise in respiratory therapies," Chief Commercial Officer Luke Miels said.

[wallywoo] 18/4/2023 08:00

$2B in cash is certainly not a small bolt on. Gsk has a mkt cap of around £60B, so this is a decent bolt on and big debt increase.


Imo, this will ensure the share price goes nowhere. I wonder why no shares where not part of the deal. Such a large increase in debt when interest rates are high, will raise eyebrows!!

[patientcapital] 18/4/2023 07:50

Small bolt on:"Following the anticipated regulatory approval and launch of camlipixant in 2026, the acquisition is expected to be accretive to adjusted EPS from 2027 and has the potential to deliver significant sales through 2031 and beyond."

[anhar] 17/4/2023 11:24

I think the reason that so-called "blockbusters" make little or no difference to the GSK share price is that there is a lack of trust in the company due to its poor record. It's possible this could be reversed if these drugs make a big difference to profits, or even if enough institutional investors think this will happen in future, but that remains to be seen.

[estienne] 17/4/2023 08:23

They're just not sure how to identify female adults and adolescents

[supermarky] 17/4/2023 08:04

Yep....so far

[tradermichael] 17/4/2023 07:54

Unbelievable response in the market to the news of a late stage potential blockbuster drug

[zho] 15/4/2023 21:27

GSK’s New Drug to Treat Urinary Infection Beats Rival in Trial

Drug outperformed competitor for urinary infections in trials
Pharma company to apply for US approval in the second quarter:

[supermarky] 14/4/2023 13:56

will gsk break resistance 1523 in run up to results 26th April?

[zho] 14/4/2023 13:45

>>I'm just trying to gauge how well GSK shares are doing compared with a year ago.>>

Not well, because there was a 5 for 4 consolidation of rump Glaxo when HLN was spun out in mid-August, so the headline price of GSK stayed pretty much the same after the split, roughly £17.

[isainvestor] 14/4/2023 13:39

A year ago GSK was around 1775p. How does the current price of (1523p) compare, taking into account the drop caused by the demerger / Haleon? What should have each GSK share dropped by - e.g. 1775p to what? I'm just trying to gauge how well GSK shares are doing compared with a year ago.

[alibizzle] 14/4/2023 08:47

I'm guessing the RSV news will come before the court case , so if GSK get the contract and shares increase is it worth cashing in then before I evitable soft Californian jury award against GSK over zantac and shares fall heavily again

[beergut] 14/4/2023 08:35

Any recent broker upgrades or down grades on this. Not that they are worth the paper they are written on.

[patientcapital] 13/4/2023 18:02

Dividends received on time.

[dancing piranha] 13/4/2023 17:53

Nope, I'm with T212

[turvart] 13/4/2023 17:46

Anyone been paid the divvy yet with Barclays? I haven’t had mine yet from Barclays regarding the GSK payment.

[alibizzle] 13/4/2023 09:37

Upwards and onwards

[tradermichael] 13/4/2023 08:45

Dividend cash in my AJ Bell accounts this morning .... ;0)